Petersdorf E W, Smith A G, Haase A M, Martin P J, Hansen J A
Division of Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington.
Tissue Antigens. 1991 Oct;38(4):169-77. doi: 10.1111/j.1399-0039.1991.tb01891.x.
We have used group-specific DNA amplification and sequence-specific oligonucleotide probe (SSOP) hybridization to study DRB1 sequence polymorphisms associated with DR3, DRw11(5), DRw12(5), DRw13(w6), DRw14(w6) and DRw8 alleles. Group-specific amplification of DRw52-associated DRB1 alleles was achieved using a 5' amplification primer designed to hybridize with a first hypervariable region (HVR) sequence common to all known alleles in this group, together with a 3' intron primer. Prospective SSOP typing of DR3, DRw11, DRw12, DRw13, DRw14 and DRw8 alleles was performed in 318 individuals, including 124 patients, 46 family members and 148 unrelated marrow donors. Among the 395 DRw52-associated DRB1 alleles tested in our study, a subtype corresponding to the previously defined alleles DRB10301-2 (DR3), DRB11101-4 (DR5), DRB11201-2 (DR5), DRB11301-5 (DRw6), DRB11401-2 and 1404 (DRw6), and DRB10801-4 (DRw8) could be assigned in all but 6 individuals (1.9%) tested. In addition to the 22 known alleles, we identified two new DRw6-associated alleles, DRB113.MW(1) and DRB114.GB(1). DRB113.MW typed serologically as DRw13 and was identical to DRB11301 except at codon 71 where AGG encodes arginine instead of GAG encoding glutamic acid. DRB114.GB represents a DRB11402 variant whose sequence at codon 86 encodes valine (GTG) instead of glycine (GGT). These results demonstrate that SSOP methods represent an efficient and precise approach for typing DRB1 alleles and for identifying potential novel variants previously unrecognized by conventional typing methods.
我们运用群体特异性DNA扩增和序列特异性寡核苷酸探针(SSOP)杂交技术,来研究与DR3、DRw11(5)、DRw12(5)、DRw13(w6)、DRw14(w6)和DRw8等位基因相关的DRB1序列多态性。利用一个5'扩增引物与该群体中所有已知等位基因共有的第一个高变区(HVR)序列杂交,并结合一个3'内含子引物,实现了与DRw52相关的DRB1等位基因的群体特异性扩增。对318名个体进行了DR3、DRw11、DRw12、DRw13、DRw14和DRw8等位基因的前瞻性SSOP分型,其中包括124名患者、46名家庭成员和148名无关的骨髓供体。在我们研究中检测的395个与DRw52相关的DRB1等位基因中,除6名个体(1.9%)外,其余个体均可分型为与先前定义的等位基因DRB10301 - 2(DR3)、DRB11101 - 4(DR5)、DRB11201 - 2(DR5)、DRB11301 - 5(DRw6)、DRB11401 - 2和1404(DRw6)以及DRB10801 - 4(DRw8)相对应的亚型。除了22个已知等位基因外,我们还鉴定出两个与DRw6相关的新等位基因,DRB113.MW(/)和DRB114.GB(/)。DRB113.MW血清学分型为DRw13,除第71密码子外与DRB11301相同,在该密码子处AGG编码精氨酸而非GAG编码谷氨酸。DRB114.GB代表DRB11402的一个变体,其第86密码子处的序列编码缬氨酸(GTG)而非甘氨酸(GGT)。这些结果表明,SSOP方法是一种高效且精确的DRB1等位基因分型方法,也是识别传统分型方法之前未识别的潜在新变体的有效途径...